Northwest Biotherapeutics, Inc. is a biotechnology company, which engages in the development of personalized immune therapies for cancer. It offers DCVax technology platform, which uses activated dendritic cells to mobilize a patient’s own immune system to attack their cancer. The company was founded by Alton L. Boynton on March 18, 1996 and is headquartered in Bethesda, MD.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
25
Frequently Asked Questions
What is Market Cap of Northwest Biotherapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Northwest Biotherapeutics Inc market cap is $378M.
What is the 52-week high for Northwest Biotherapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Northwest Biotherapeutics Inc 52 week high is $0.4788 as of September 27, 2025.
What is the 52-week low for Northwest Biotherapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Northwest Biotherapeutics Inc 52 week low is $0.1684 as of September 27, 2025.
What is Northwest Biotherapeutics Inc stock price today?
Northwest Biotherapeutics Inc stock price today is $0.255.
What was Northwest Biotherapeutics Inc stock price yesterday?
Northwest Biotherapeutics Inc stock price yesterday was $0.25.
What is the PE ratio of Northwest Biotherapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Northwest Biotherapeutics Inc’s P/E ratio is -4.04.
What is the Price-to-Book ratio of Northwest Biotherapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Northwest Biotherapeutics Inc P/B ratio is -3.7086.
What is the 50-day moving average of Northwest Biotherapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Northwest Biotherapeutics Inc 50-day moving average is $0.2514.
How many employess does Northwest Biotherapeutics Inc has?